Because K-Ras activation is the most frequently detected genetic alteration in human tumours, identification of therapeutic targets for K-Ras activated tumours and resistance mechanisms to K-Ras inhibition would be of enormous therapeutic relevance. The gene discussed is KRAS; the disease is neoplasm.